BALANCED INFUSION SOLUTION
专利「BALANCED INFUSION SOLUTION」由 EcoPharm Patent Management AG 持有，当前状态为Abandoned，申请号 P/366。LaoBiz 老商通提供老挝知识产权信息检索与企业关联查询。
Patent “BALANCED INFUSION SOLUTION” is held by EcoPharm Patent Management AG; status: Abandoned. Search Laos IP records on LaoBiz.
P/366
图样
基础信息
- 类型
- 专利
- 申请号
P/366- 状态
- Abandoned
- 申请人
- EcoPharm Patent Management AG
- 代理机构
- CONCETTI-LAO CO., LTD
- 申请日期
- 2015-05-18
- 公开/公告日
- 2026-01-09
- 国际分类
- A61K 31/00 · A61K 31/19 · A61K 33/14 · A61K 9/08
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The invention is related to medicine and pharmacology, in particular, to salt infusion solutions having detoxicating effect, and may be used for treatment of diseases and conditions associated with organism intoxications of various severity degrees. The objective of the invention is to provide a novel, balanced infusion solution having higher detoxicating activity, low toxicity and ensuring a broad area of clinical application. The above-stated objective is attained by provision of a balanced infusion solution containing sodium, potassium and magnesium chlorides, a solvent and a biologically active ingredient, which, in accordance with the invention, includes sodium L-arginine succinate of the formula: Na+[NH=C(NH)2NH(CN2)3CH(NH2)COOH]+[OOC(CH2)2COO]2- As the biologically active ingredient, proportion of the components being as follows (% by mass): Sodium chloride 0.540-0.600 Magnesium chloride hexahydrate 0.015-0.030 Potassium chloride 0.025-0.040 Sodium L-arginine succinate 1.400-1.700 Water of injections the balance.
The invention is related to medicine and pharmacology, in particular, to salt infusion solutions having detoxicating effect, and may be used for treatment of diseases and conditions associated with organism intoxications of various severity degrees. The objective of the invention is to provide a novel, balanced infusion solution having higher detoxicating activity, low toxicity and ensuring a broad area of clinical application. The above-stated objective is attained by provision of a balanced infusion solution containing sodium, potassium and magnesium chlorides, a solvent and a biologically active ingredient, which, in accordance with the invention, includes sodium L-arginine succinate of the formula: Na+[NH=C(NH)2NH(CN2)3CH(NH2)COOH]+[OOC(CH2)2COO]2- As the biologically active ingredient, proportion of the components being as follows (% by mass): Sodium chloride 0.540-0.600 Magnesium chloride hexahydrate 0.015-0.030 Potassium chloride 0.025-0.040 Sodium L-arginine succinate 1.400-1.700 Water of injections the balance.